ICU Medical ICUI · NASDAQ
$172.62 +6.67% (+$10.79)
Summary
34 / 100 · Bulios Score
What speaks for it
- It beat profit estimates 8 times in the last 8 quarters.
What to watch
- Operating profit does not even cover the interest on its debt.
- The share price is above the Bulios Fair Price.
- Revenue fell by 0.7% a year over the last 3 years.
- Out of every 100 USD of revenue, only 1.4 USD is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 143.5 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 12% a year over 5 years. Over the last 3 years it fell by 0.7% a year. For the next fiscal year analysts expect revenue to fall by 1.9%.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 62 USD
- Research and development 4.0 USD
- Sales and administration 29 USD
- Taxes and other 3.6 USD
- Net profit 1.4 USD
Net profit, industry median (Medical - Instruments & Supplies) 7.7 USD
Out of every 100 USD of revenue, 1.4 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 8.3 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 11
- Hold 1
- Sell 0
Today's price within the analysts' price targets
The average target of $186.4 is 8.0% above today's price. 92% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Equipment revenue 70%
- Software revenue 29%
- Other deferred revenue 1.1%
By region
- UNITED STATES 61%
- EMEA 18%
- Asia Pacific 10%
- Other foreign countries 10%
Equipment revenue brings in 70% of revenue.
Segments in detail